Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-059478
Filing Date
2024-05-14
Accepted
2024-05-14 16:00:42
Documents
67
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q isco-20240331.htm   iXBRL 10-Q 1265641
2 EX-31.1 isco-ex31_1.htm EX-31.1 12152
3 EX-31.2 isco-ex31_2.htm EX-31.2 12124
4 EX-32.1 isco-ex32_1.htm EX-32.1 7318
5 EX-32.2 isco-ex32_2.htm EX-32.2 7887
  Complete submission text file 0000950170-24-059478.txt   7002115

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT isco-20240331.xsd EX-101.SCH 1052955
71 EXTRACTED XBRL INSTANCE DOCUMENT isco-20240331_htm.xml XML 1336640
Mailing Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008
Business Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008 760-940-6383
International Stem Cell CORP (Filer) CIK: 0001355790 (see all company filings)

EIN.: 204494098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51891 | Film No.: 24944041
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)